Eco Animal Health Group PLC Capital Markets Day Events (8683S)

TIDMEAH

RNS Number : 8683S

Eco Animal Health Group PLC

09 November 2023

9 November 2023

ECO Animal Health Group plc

Capital Markets Day Events - R&D Portfolio

ECO Animal Health Group plc (AIM: EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, is pleased to announce that it will be hosting two Capital Markets events focused on progress and developments in the Company's Research & Development portfolio today, Thursday 9 November 2023.

No new material information will be disclosed at the events.

For further information please contact:

 
 ECO Animal Health Group plc 
  David Hallas (CEO) 
  Christopher Wilks (CFO)                     020 8447 8899 
 IFC Advisory 
  Graham Herring 
  Zach Cohen                                  020 3934 6630 
 Singer Capital Markets (Nominated Adviser 
  & Joint Broker) 
  Phil Davies 
  Sam Butcher                                 020 7496 3000 
 Investec (Joint Broker) 
  Gary Clarence 
  Lydia Zychowska 
  Carlo Spingardi                             020 7597 5970 
 Equity Development 
  Hannah Crowe 
  Matt Evans                                  020 7065 2692 
 

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new products.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCMZMGMGLGGFZG

(END) Dow Jones Newswires

November 09, 2023 02:00 ET (07:00 GMT)